Inhibition of cell proliferation and protease activity by cartilage factors and heparin
- 1 January 1980
- journal article
- research article
- Published by Wiley in Journal of Supramolecular Structure
- Vol. 14 (1), 33-46
- https://doi.org/10.1002/jss.400140105
Abstract
Proliferating rat smooth muscle cells and fibroblasts have membrane-associated protease activity. High concentrations of heparin inhibited membrane-associated protease activity and cell proliferation, while low concentration of heparin promoted smooth muscle cell proliferation. The inhibition of protease activity and proliferation was abolished when heparin was treated with protamine sulfate or when acid treated fetal calf serum was used. Heparin required the presence of an acid labile factor(s) in serum for the inhibition of protease activity and proliferation. Heparin and antithrombin III in the presence of acid-treated fetal calf serum did not inhibit cell proliferation or protease activity. Cartilage factors isolated from bovine nasal cartilage containing trypsin inhibitory activity, but not papain inhibitory activity, inhibited rat smooth muscle and fibroblast proliferation and surface associated protease activity. The cartilage factors did not require acid-labile components in the fetal calf serum for the inhibitory activity. The inhibitory activity due to heparin and cartilage factors was not permanent under our experimental condition. Protein synthesis was not inhibited by heparin or the cartilage factors. In rat smooth muscle cells and fibroblasts, the expression of surface-associated protease activity was related to the proliferative state of the cells. Surface protease activity was only present on proliferating cells. When surface protease activity was inhibited by high concentrations of heparin in the presence of an acid-labile serum component(s) or cartilage factors, cell proliferation was also inhibited.Keywords
This publication has 37 references indexed in Scilit:
- Heparin releases heparan sulfate from the cell surfaceBiochemical and Biophysical Research Communications, 1977
- Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activityExperimental Cell Research, 1977
- The relationship between surface protease activity and the rate of cell proliferation in normal and transformed cellsBiochemical and Biophysical Research Communications, 1977
- Cell surface-associated and released proteolytic activities of bovine aorta endothelial cellsBiochemical and Biophysical Research Communications, 1976
- Collagenase inhibition by cationic proteins derived from cartilage and aortaBiochemical and Biophysical Research Communications, 1976
- Proteolytic activity associated with human erythrocyte membranes. Self-digestion of isolated human erythrocyte membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1975
- Proteinase inhibitor activity in connective tissuesCellular and Molecular Life Sciences, 1974
- A Theory of Lymphocyte Blast Transformation (LBT) and Malignant Change Based on Proteolytic Cleavage of a Trigger Peptide: the DetendomerOncology, 1974
- Involvement of proteolytic activity in early events in lymphocyte transformation by phytohemagglutininBiochemical and Biophysical Research Communications, 1973
- The influence of proteolytic enzymes inhibitor on the course of lymphocyte transformation in vitroCellular and Molecular Life Sciences, 1972